Please login to the form below
Italy
This page shows the latest Italy news and features for those working in and with pharma, biotech and healthcare.
UK Supreme Court rules in favour of Servier in NHS patent lawsuit
First launched in 1976, Mediator was not taken off the market in France until 2009, several years after being withdrawn from other European countries, including Spain in 2003 and Italy in
Latest news
-
FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
Italy’s Chiesi Global Rare Diseases has gained approval from the US Food and Drug Administration (FDA) for the expanded use of its sickle cell disease (SCD) treatment Ferriprox.
-
Italy accelerates the path towards digital therapeutics implementation
PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy. ... group within the frame of the Smith Kline Foundation project ‘Digital Therapies for Italy – #DTxITA’.
-
EMA review confirms AZ/Oxford's COVID-19 vaccine is safe and effective
European countries including Germany, France and Italy are expected to resume administering the AstraZeneca/Oxford University vaccine after EU regulators deemed the jab safe to use following a careful review.
-
Benefits of AZ COVID-19 vaccine 'continue' to outweigh risks, says EMA’s executive director
Cooke. However, a total of 13 EU countries, including Germany, France, Italy and Sweden, have suspended the use of the vaccine while the EMA concludes its investigation into the reported blood
-
EMA says there is ‘no indication’ AZ/Oxford’s COVID-19 vaccine causes blood clots
Other EU member states – Italy and Austria – have suspended vaccination from certain batches of the vaccine, although the suspensions in each country involves different batches. ... the same batch of vaccines currently suspended in Italy.
FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
Italy accelerates the path towards digital therapeutics implementation
EMA review confirms AZ/Oxford's COVID-19 vaccine is safe and effective
Benefits of AZ COVID-19 vaccine 'continue' to outweigh risks, says EMA’s executive director
More from news
Approximately 7 fully matching, plus 411 partially matching documents found.
Latest Intelligence
-
Back to the future
Professor Brian D Smith researches the evolution of the life sciences industry at both the University of Hertfordshire, UK and Bocconi University, Italy.
-
Shaping the organisation to enable intelligent, precision engagement
While around 50% of healthcare professionals (HCPs) in Germany, France and Italy are willing to see reps, physicians in the UK do not expect to accept visits for another two to
-
The flexible salesforce
In Spain, other channels went from 12% of total activity in January to 94% in May, Italy 9% to 96% and Brazil 15% to 89% (Figure 2). ... In Italy a peak of 41% was reached in May but this has now fallen back to 11%.
-
Addressing the payer-regulator evidence gap in early-stage cancer
In December 2018, IQVIA and AstraZeneca conducted a blinded survey of 65 payers in eight countries (Australia, Canada, France, Germany, Italy, Spain, UK, USA) which found a lower awareness of
-
Things are going to be different
China has a near 600% increase, Korea 165%, Italy 286% and Spain 145%.
Back to the future
Shaping the organisation to enable intelligent, precision engagement
The flexible salesforce
Addressing the payer-regulator evidence gap in early-stage cancer
More from intelligence
Approximately 2 fully matching, plus 58 partially matching documents found.
Latest appointments
-
ICR appoints Kristian Helin as its new chief executive
Helin was founding director of a scientific institute in his native Denmark, and has previously led research centres in Italy and the US, and also founded biotech company EpiTherapeutics.
-
Health comms agency emotive hires new cell and gene therapy leader
Silvana holds a PhD in Molecular Genetics from the Human Molecular Genetics Unit at the University of Insurbia in Italy. ... scientific institutions across the globe, including Singapore, Switzerland, London, Belgium, theUS and Italy.
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
He started his career with Eurand in Italy, and since 2011 he has worked for Helsinn Healthcare, a cancer care company.
-
Paolo Carli appointed as head of MEA at Merck
Prior to his time at Merck, Carli worked with Deutsche Bank, both in Italy and Germany, where he contributed to the regional expansion of the retail franchise in Europe and several
-
Nabriva Therapeutics appoints new chief commercial officer
He has also held roles at UCB Pharma and 3M in Italy.
ICR appoints Kristian Helin as its new chief executive
Health comms agency emotive hires new cell and gene therapy leader
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Paolo Carli appointed as head of MEA at Merck
Nabriva Therapeutics appoints new chief commercial officer
More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.
Latest from PMHub
-
Dovetail partners with Tillotts AG to map management of C. difficile infection in Europe
Dovetail's support will help the company to gain insights into the strategic context for, and operational practicalities of CDI management in Italy and Greece.
-
The heavy toll of COVID-19 on cancer patients
The rate of skin cancer diagnosis dropped the most. In Italy, cancer diagnoses fell by 39% during lockdown, compared to the two previous years.
-
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
I wasn’t long returned from my year out as an Au-Pair in Italy, and given that I hadn’t even packed a skirt when I left Scotland for my
-
Will COVID-19 necessitate a change in thinking around clinical trials?
With Italy in lockdown and other countries possibly following suit, will this outbreak impact ongoing clinical studies and those currently enrolling patients?
-
PHARMA CONTENT MARKETING COMES OF AGE - ‘15 MINUTES OF FURY’ A MENTAL HEALTH & SOCIAL MEDIA FILM
We are headquartered in London with satellite offices in Los Angeles, New York, and Salerno, Italy.
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Will COVID-19 necessitate a change in thinking around clinical trials?
PHARMA CONTENT MARKETING COMES OF AGE - ‘15 MINUTES OF FURY’ A MENTAL HEALTH & SOCIAL MEDIA FILM
More from PMHub
Approximately 0 fully matching, plus 44 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
-
Midweight-Senior Creative
-
Competitive Salary Offered
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Understanding the ‘real world’ starts and ends with the patient
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- J&J and Pfizer quietly resolve Remicade biosimilar lawsuit
- CONGREGO™ IS NOW MULTI-PLATFORM
- Onyx Health Marks Record Growth with Six New Appointments
- FDA expands use of COVID-19 antibody cocktail
- New European supply deals show Pfizer and Moderna have increased COVID-19 vaccine prices
- Ipsen’s spending spree bolsters neurology pipeline
- AMICULUM® launches Cence, a new specialist publications agency
- The future of office working designed with our people in mind: ‘Work Where You Work Best’, an Evoke KYNE model
- GSK, Vir’s sotrovimab cuts hospitalisation and death risk by 79% in COVID-19 outpatients
- Biogen and Ionis post ‘encouraging’ early results for Alzheimer’s disease candidate
- Eylea set to challenge Lucentis in UK after NICE recommendation
- Onyx Health Launch Creative Studio After Record Year
- BioNTech to use mRNA technology to develop a ‘highly effective’ malaria vaccine
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Guide
- How to embrace behavioural science principles in healthcare MR...
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
